Page last updated: 2024-08-22

trolamine salicylate and Leukemia, Myelomonocytic, Acute

trolamine salicylate has been researched along with Leukemia, Myelomonocytic, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexander, CB; DeAngelo, DJ; Helfgott, SM; Schwarzberg, AB1
Aroni, KG; Boki, KA; Kordossis, T; Stamoulis, K; Tzavara, V1

Other Studies

2 other study(ies) available for trolamine salicylate and Leukemia, Myelomonocytic, Acute

ArticleYear
Clinical problem-solving. A joint venture.
    The New England journal of medicine, 2008, Jun-05, Volume: 358, Issue:23

    Topics: Arthritis; Bone Marrow; Diagnosis, Differential; Dyspnea; Exanthema; Eye; Fatigue; Female; Humans; Joints; Leukemia, Myelomonocytic, Acute; Leukemic Infiltration; Leukocytes, Mononuclear; Middle Aged; Skin; Synovial Fluid; Urinary Bladder Neoplasms

2008
Facial heliotrope rash as the initial manifestation of acute myelomonocytic leukemia.
    Leukemia & lymphoma, 1997, Volume: 25, Issue:3-4

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arthritis; Bone Marrow; Cytarabine; Dermatitis; Face; Granulocyte Colony-Stimulating Factor; Humans; Keratosis; Leukemia, Myelomonocytic, Acute; Male; Mitoxantrone; Pancytopenia; Parotid Gland; Prednisolone

1997